Results 321 to 330 of about 4,977,534 (400)

Coronary Artery Fistulous Perforation Effectively Managed During Chronic Total Occlusion Recanalization: A Case Report

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary perforation is a feared complication of chronic total occlusion‐percutaneous coronary intervention (CTO‐PCI), especially in large vessel perforations, which often require implantation of covered stents (CS). However, the deployment of multiple CSs may not always be effective.
Gao Haokao   +3 more
wiley   +1 more source

Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self‐Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database‐NTCVR

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter aortic valve replacement (TAVR) for pure native aortic regurgitation (PNAR) remains challenging. While the noncoronary sinus pivot implantation (NCPI) strategy showed promise with VitaFlow valve, its efficacy with other valves needs validation. Aims This study aims to evaluate the real‐world efficacy of the TaurusElite
Feng Xia   +11 more
wiley   +1 more source

Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT We aimed to compare the long‐term efficacy and safety of drug‐coated balloon (DCB) and drug‐eluting stent (DES) following atherectomy for coronary arteries with severely calcified lesions. Of the 258 consecutive patients and 422 de novo lesions treated with DCB at Kanazawa Medical University Hospital, we retrospectively enrolled highly ...
Taka‐aki Takamura   +11 more
wiley   +1 more source

Role of macrophages in regression of myocardial fibrosis following alleviation of left ventricular pressure overload.

open access: yesAm J Physiol Heart Circ Physiol
Neff LS   +9 more
europepmc   +1 more source

Long‐Term Survival After Post‐Myocardial Infarction Ventricular Septal Defect (VSD) Closure, Multiple Percutaneous Coronary Interventions and Edge‐to‐Edge Repair

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT This reports a case of a female aged 65 who presented in cardiogenic shock secondary to an inferior ST‐elevation myocardial infarction and was diagnosed with a post‐infarction ventricular septal defect (VSD) and was also found to have severe mitral valve regurgitation. She was not surgically operable, so underwent percutaneous VSD repair. Over
Heidi Turner   +3 more
wiley   +1 more source

Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Patients with hypertrophic obstructive cardiomyopathy (HOCM) were excluded from all major trials for transcatheter aortic valve replacement (TAVR). “Suicide left ventricle” occurring after TAVR is postulated to occur as a result of chronic pressure overload from fixed obstruction that is acutely relieved after the valve deployment ...
Muhammad Usman Almani   +6 more
wiley   +1 more source

Redo‐Transcatheter Aortic Valve Replacement With a 26 mm Sapien Valve in a 26 mm Evolut Valve to Correct Significant Paravalvular Leak via Transcarotid Access

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT An 84‐year‐old man with multiple comorbidities including severe aortic stenosis, heart failure with a reduced ejection fraction, severe peripheral artery disease with prior bilateral iliac artery stents, and trifascicular block presented for evaluation for aortic valve replacement.
Charlene L. Rohm   +4 more
wiley   +1 more source

Transfemoral Transcatheter Aortic Valve Implantation (TF‐TAVI) for Patients With Left Ventricular Assist Device (LVAD) and Aortic Regurgitation

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Aortic regurgitation (AR) develops in up to 25%−30% of patients with left ventricular assist device (LVAD). Treatment remains challenging since surgery confers significant peri‐operative risk and the lack of valvular calcification renders transfemoral transcatheter aortic valve implantation (TF‐TAVI) with non‐dedicated devices technically ...
Daniel Tai‐Leung Chan   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy